of FV antigen, the immobilized monoclonal antibody CLB-FV-4 4 was used and purified FV with known concentration served as reference.
Construction of FVIII-YFP/FV chimera pcDNA3.1(+) vectors
For construction of FVIII containing a FV C1-or C2-domain, FV C-domains were amplified from pcDNA3.1(+) encoding B-domain deleted FV 811-1491 6 using the following primers for the FV C1-domain:
5'-ATAACCGGTGGACTAAGCACTGGTATC-3' (sense) and 5'-TATTGGCGCGCCACCATTTACCTCACAACCTTG-3'(antisense).
For the FV C2-domain the following primers were used:
5'-ATAACGGTGGATGTTCCACACCCCTG-3' (sense) and 5'-TATTGGCGCGCCACCGTAAATATCACAGCCAAA-3' (antisense).
PCR products were ligated in pGEM-T Easy vector (Promega) and digested with AgeI and AscI. The FVIII C1-(ranging from Cys2021 to Asp2172) or C2-domain (ranging from Ser2173 to the C-terminal end) in pcDNA3.1(+) FVIIIYFP 7 were replaced for AgeI-AscI restriction sites by Quick Change mutagenesis using the following primers for the C1-domain (restriction sites are underlined): 
Construction of lentiviral vectors

TMT-labeling of FVIII-YFP variants and mass spectrometry analysis
TMT-labeling was done as essentially described elsewhere. 8 Briefly, labeling was initiated by addition of 2.5 mM of TMT labels to 140 nM of the chimeric FVIII-YFP/FV protein or 140 nM of the normal FVIII-YFP protein in buffer containing 20 mM HEPES, 5 mM CaCl 2 and 175 mM NaCl and incubated at 25 °C (Eppendorf Thermomixer comfort, 600 rpm). In our experiments, TMT-127 was used for the chimeric protein and TMT-126 was used for the FVIII-YFP or FV. The labeling reaction was quenched after 15 minutes by addition of 500 mM of hydroxylamine. TMT-labeled wild-type protein was pooled in a 1:1 molar ratio with either TMT-labeled FVIII-YFP/FV-C1 or FVIII-YFP/FV-C2. The pooled protein mixture was reduced and acetylated as described previously. 8 Peptides were obtained after digestion by chymotrypsin with subsequent desalting using a C18 Ziptip (Millipore, Amsterdam, the Netherlands), both performed according to the manufacturer's instructions. Peptides were separated by reverse phase chromatography and sprayed into a Thermo Scientific LTQ OrbitrapXL mass spectrometer. Peptides from the chimeras and FVIII-YFP were separated on a C18 column with 0.5% (v/v) acetic acid using two different gradients from 0% up to 60% (v/v) of acetonitrile: a (short) 60 minute gradient and a (long) 160 minute gradient both with a wash peak of 98% (v/v) acetonitrile for 5 minutes. Peptides acquired from the chimeras and FV wild-type were separated using the long 160 minute gradient. Peptide identification and TMT quantification by mass spectrometric analysis was done as described elsewhere. were passed over a chip with different VWF densities (7 fmol/mm 2 , 24 fmol/mm 2 and 37 fmol/mm 2 ). Spikes are due to minor differences in buffer composition between samples and running buffer. Ignoring these imperfections, sensorgrams of FVIII-YFP and FVIII-YFP/FV-C2 were fitted using a Langmuir 1:1 binding model. 9 The association phase was fitted using a k off value obtained from a separate dissociation phase fitting (also using a Langmuir 1:1 binding model). 9 
